All stock lists
ArriVent BioPharma, Inc. (NASDAQ:AVBP)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
13.35-1.52 (-10.22%)
Market cap
$658M
Insider Score
Health Score
Analyst consensus
Listed since
Jan 26, 2024
Website
Insider Score
––Not scored
AVBP Insider Score
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
AVBP analyst forecast
AVBP analyst consensus
Moderate Buy7 ratings
Buy 7 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
AVBP 12-month price target
$25.67+92.3% upsideaverage of 3 firms
$29.00High
$21.00Low
AVBP ratings mix, last 12 months
Buy Hold Sell
Best analysts covering AVBP
- Guggenheim100%success rate · +38.5% avg return · 1 call
- HC Wainwright & Co.60%success rate · +14.6% avg return · 10 calls
- Citigroup50%success rate · +30.3% avg return · 2 calls
- Oppenheimer33%success rate · -3.5% avg return · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
AVBP analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Guggenheim | Buy | — | — | Reiterated | 2026-10-27 |
| Truist Financial | — | $21.00 | +36.7% | — | 2026-10-26 | |
| — | B. Riley Securities | Buy | — | — | Reiterated | 2026-10-20 |
| — | BTIG | Buy | — | — | Reiterated | 2026-10-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-10-08 |
| H.C. Wainwright | — | $27.00 | +59.9% | — | 2026-10-08 | |
| — | Citigroup | Buy | — | — | Reiterated | 2026-10-07 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-10-07 |
| BTIG | Buy | $29.00 | +92.2% | Reiterated | 2026-10-07 | |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-10-07 |
| — | Jones Trading | Buy | — | — | Reiterated | 2026-10-07 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-08-17 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-08-13 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-08-13 |
| — | BTIG | Buy | — | — | Reiterated | 2026-08-13 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-05-29 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-05-13 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-04-24 |
| — | B. Riley Securities | Buy | — | — | Reiterated | 2026-03-23 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-03-06 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-03-06 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-03-06 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-11-11 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-08-12 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-08-12 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-07-22 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-06-24 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-06-24 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-05-14 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-03-07 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-01-22 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-15 |
| — | Citigroup | Buy | — | — | Reiterated | 2024-09-11 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2024-09-10 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2024-09-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-09-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-08-16 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2024-08-15 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-06-06 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-09 |
AVBP earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2025-11-10 | -0.78 | -0.83 | $0 | $0 |
| 2026-03-05 | -0.87 | -0.78 | $0 | $0 |
| 2026-05-11 | -0.88 | -0.96 | $0 | $0 |
| 2026-08-12 | -0.99 | -1.05 | $0 | $0 |
| 2026-11-16Upcoming | -1.04 | — | $800K | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.